REGN

Q: What is the price of Regeneron Pharmaceuticals (REGN) today?

The price of Regeneron Pharmaceuticals (REGN) today is US$ 564,63, with a variation of -43.24% compared to the last year. The price of Regeneron Pharmaceuticals (REGN) started the year trading around US$ 712,33 and today it is at US$ 564,63. Follow the real-time price chart, the historical price of Regeneron Pharmaceuticals (REGN), and stock data from Ibovespa and international markets.

Q: When does Regeneron Pharmaceuticals (REGN) pay dividends?

Regeneron Pharmaceuticals (REGN) distributed dividends in the last year,in the months of March, June and September totaling US$ 2,64. The Dividend Yield for the last 12 months is 0,44%.

Q: Regeneron Pharmaceuticals (REGN) is it worth it?

Currently, Regeneron Pharmaceuticals (REGN) is priced at US$ 564,63, with a P/E of 13,97%, representing a deviation of 15,19% from its historical average P/E. In the last year, the stock showed a variation of -43.24% in its price and distributed US$ 2,64 in dividends, resulting in a Dividend Yield of 0,44%. The total shareholder return was -43,24%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Regeneron Pharmaceuticals (REGN)?

Investing in stocks of Regeneron Pharmaceuticals (REGN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Regeneron Pharmaceuticals (REGN) yield today?

The yield of Regeneron Pharmaceuticals (REGN) was 1,58% in the last month, -43,24% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 2,64 in dividends, um Dividend Yield de 0,44%.If you wanted to buy 100 stocks of Regeneron Pharmaceuticals (REGN) today, the total investment would be US$ 56.463,00, based on the current price of US$ 564,63.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 32.048,40In 5 years: US$ 56.463,00In 10 years: 56.463,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Regeneron Pharmaceuticals Inc.

Price

US$ 564,63

variation (12m)

-43,24%

p/l

13,97

p/vp

2,10

DIVIDEND YIELD

0,44%

price REGN

BVMF

REGN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of REGN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,58%

3 months

-0,39%

1 year

-43,24%

2 years

-32,17%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

1,58%

3 months

-0,76%

1 year

-45,73%

2 years

-38,09%

5 years

0,00%

10 years

0,00%

Indicators REGN

check out the fundamentals of Regeneron Pharmaceuticals shares

P/E

13,97

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

4,45

Sector: -4,23 Industry: -4,23

P/BV

2,10

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

0,44%

Sector: - Industry: -

ROA

11,80%

Sector: -63,87% Industry: -63,87%

ROE

15,06%

Sector: -70,87% Industry: -70,87%

ROIC

25,44%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

31,83%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

85,25%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

26,50%

Sector: -41,04% Industry: -41,04%

P/EBITDA

12,16

Sector: -3,65 Industry: -3,65

P/EBIT

12,79

Sector: -3,64 Industry: -3,64

P/ASSET

1,65

Sector: 1,41 Industry: 1,41

BVPS

285,13

Sector: 1,84 Industry: 1,84

EPS

42,95

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,78

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

9,59%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

3,87%

Sector: - Industry: -

FAIR PRICE OF Regeneron Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 564,63

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-7,03%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

REGN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of REGN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History REGN

current DY: 0,44%

5-year average DY: 0,44%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	18/08/2025	03/09/2025	0,88000000
Dividends	20/05/2025	06/06/2025	0,88000000
Dividends	20/02/2025	20/03/2025	0,88000000

ABOUT THE COMPANY Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc.

Average user rating I10

5.0 (43 people)

Estados Unidos

37 years

Foundation: 1988

1991

Year of debut on the stock exchange - 34 years

9.123

Employees

The Company Regeneron Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 63,00 Billions, having a net worth of $ 29,94 Billions.

With a total of 9.123 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 14,17 Billions, which generated a profit in the amount of $ 4,51 Billions.

As for its main indicators, the Company has a P/E ratio of 13,97, a P/BV ratio of 2,10 and in the last 12 months the dividend yield of REGN was at 0,44%.

The Company is traded internationally through the ticker REGN.

Market value

US$ 63,00 Billions

Net worth

US$ 29,94 Billions

US$ 29.938.900.000,00

Assets

US$ 38,22 Billions

US$ 38.219.200.000,00

Total Number of Shares

105,00 Milhões

105.000.000

Average Daily Trading Volume

US$ 1,05 Million

US$ 1.050.324,00

Sector

Health Care

Industry

Biotechnology

REGN

REGN revenue and profits

REGN results

DRAG THE FRAME TO SEE MORE DATA

REGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Regeneron Pharmaceuticals (REGN) today?

The price of Regeneron Pharmaceuticals (REGN) today is US$ 564,63, with a variation of -43.24% compared to the last year. The price of Regeneron Pharmaceuticals (REGN) started the year trading around US$ 712,33 and today it is at US$ 564,63. Follow the real-time price chart, the historical price of Regeneron Pharmaceuticals (REGN), and stock data from Ibovespa and international markets.

When does Regeneron Pharmaceuticals (REGN) pay dividends?

Regeneron Pharmaceuticals (REGN) distributed dividends in the last year,in the months of March, June and September totaling US$ 2,64. The Dividend Yield for the last 12 months is 0,44%.

Regeneron Pharmaceuticals (REGN) is it worth it?

Currently, Regeneron Pharmaceuticals (REGN) is priced at US$ 564,63, with a P/E of 13,97%, representing a deviation of 15,19% from its historical average P/E. In the last year, the stock showed a variation of -43.24% in its price and distributed US$ 2,64 in dividends, resulting in a Dividend Yield of 0,44%. The total shareholder return was -43,24%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Regeneron Pharmaceuticals (REGN)?

Investing in stocks of Regeneron Pharmaceuticals (REGN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Regeneron Pharmaceuticals (REGN) yield today?

The yield of Regeneron Pharmaceuticals (REGN) was 1,58% in the last month, -43,24% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 2,64 in dividends, um Dividend Yield de 0,44%.

If you wanted to buy 100 stocks of Regeneron Pharmaceuticals (REGN) today, the total investment would be US$ 56.463,00, based on the current price of US$ 564,63.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 32.048,40
In 5 years: US$ 56.463,00
In 10 years: 56.463,00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

REGN

Regeneron Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of REGN

check out the fundamentals of Regeneron Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,44%

5-year average DY: 0,44%

type

date with

payment date

value

ABOUT THE COMPANY Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc.

Estados Unidos

37 years

1991

9.123

PROFIT X PRICE REGN

REGN results

REGN cash flow

evolution of assets - REGN

REGN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions